Opportunity Information: Apply for RFA CA 20 049

The New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not Allowed) funding opportunity (RFA-CA-20-049) is a National Cancer Institute (NCI) cooperative agreement designed to launch brand-new prospective cohort studies that can answer important, unresolved questions about how environmental exposures contribute to cancer risk and the biological steps involved in carcinogenesis. The central aim is to build forward-looking cohorts that collect exposure information and health outcomes over time, closing major gaps in what is known about cancer causes, especially where exposure data have historically been weak, inconsistent, or missing.

A defining feature of this opportunity is its strong emphasis on environmental exposures, broadly defined as physical, chemical, and biological factors outside the individual, along with related behavioral factors that shape exposure or response. The FOA pushes applicants to go beyond traditional questionnaires alone and instead use validated, reproducible, and innovative exposure measurement methods that are well matched to the scientific questions being asked. In practical terms, this encourages approaches such as improved biomonitoring, wearable or sensor-based measurements, geospatial or environmental monitoring linkages, and other modern strategies that can capture exposure timing, intensity, mixtures, and variability with higher accuracy and comparability.

Equity and representation are core expectations rather than optional enhancements. The cohorts are expected to include racial and ethnic minority groups and other understudied populations, with the explicit goal of addressing the unequal burden of cancer experienced by these communities. That focus signals that proposals should be intentional about recruitment, retention, community engagement, culturally appropriate study operations, and data completeness, so that the resulting cohort can support credible analyses of disparities, susceptibility, and exposure differences that may drive unequal cancer outcomes.

This FOA uses the UG3/UH3 phased cooperative agreement structure. In general, that means projects start with a time-limited planning and start-up phase (UG3) with specific milestones, and only transition to the implementation phase (UH3) after demonstrating that the cohort can be successfully launched and managed according to those milestones. As a cooperative agreement, substantial involvement from NCI is expected, typically through shared governance, milestone-driven oversight, and coordination across projects to maximize scientific value and harmonization. Clinical trials are not allowed under this announcement, reinforcing that the intent is observational cohort infrastructure and etiologic research rather than testing interventions.

The cohort awards funded through this announcement are meant to operate as part of a broader program. This FOA was published in parallel with a separate companion solicitation for a CEECR Coordinating Center (RFA-CA-20-050; U24), and together the funded cohorts plus the coordinating center form the Cohorts for Environmental Exposure and Cancer Risk (CEECR) program. The coordinating center concept implies an expectation that individual cohorts will align on shared practices where feasible, such as common data elements, exposure assessment standards, biospecimen procedures, quality control, governance policies, and cross-cohort collaboration to enable pooled or comparative analyses.

From an administrative standpoint, the opportunity is offered by the U.S. Department of Health and Human Services through the National Institutes of Health, with NCI as the sponsoring institute. It is categorized as discretionary funding and uses a cooperative agreement mechanism. The listed CFDA numbers are 93.113, 93.393, and 93.399. The anticipated scale of funding includes an award ceiling of $750,000, with an expected five awards. The original posting lists a creation date of October 14, 2020 and an original closing date of January 29, 2021.

Eligibility is broad and includes many organization types that could realistically build and sustain prospective cohorts. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and private institutions of higher education; federally recognized tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses) and small businesses; and other entities as described in the full announcement’s eligibility language. This wide eligibility aligns with the program’s need for multidisciplinary capacity, access to diverse populations, and the operational infrastructure required to recruit, follow, and measure exposures and outcomes over time.

Overall, the CEECR UG3/UH3 opportunity is best understood as an investment in new cohort infrastructure and high-quality exposure science aimed at strengthening causal evidence about environmental contributors to cancer, while also ensuring that the resulting knowledge base is relevant to populations that have often been left out of large cohort research and that bear disproportionate cancer burdens.

  • The Department of Health and Human Services, National Institutes of Health in the education, environment, health sector is offering a public funding opportunity titled "New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.113, 93.393, 93.399.
  • This funding opportunity was created on Oct 14, 2020.
  • Applicants must submit their applications by Jan 29, 2021. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $750,000.00 in funding.
  • The number of recipients for this funding is limited to 5 candidate(s).
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
Apply for RFA CA 20 049

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs): New Cohorts for Environmental Exposures and Cancer Risk (CEECR) UG3/UH3 (RFA-CA-20-049)

What is this funding opportunity?

This is the New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not Allowed) funding opportunity, RFA-CA-20-049. It is a National Cancer Institute (NCI) cooperative agreement intended to launch brand-new prospective cohort studies focused on environmental exposures and cancer risk.

What is the main goal of the CEECR UG3/UH3 awards?

The central goal is to build forward-looking prospective cohorts that collect environmental exposure information and health outcomes over time, specifically to answer important unresolved questions about how environmental exposures contribute to cancer risk and the biological steps involved in carcinogenesis.

What kind of studies does this FOA support?

This FOA supports new prospective cohort studies. The intent is observational cohort infrastructure and etiologic research, not intervention testing.

Are clinical trials allowed under this announcement?

No. Clinical trials are not allowed under this funding opportunity.

How does this FOA define "environmental exposures"?

Environmental exposures are broadly defined and include physical, chemical, and biological factors outside the individual, along with related behavioral factors that shape exposure or response.

What does the FOA emphasize about exposure measurement?

The FOA emphasizes using validated, reproducible, and innovative exposure measurement methods that match the scientific questions being asked. It encourages applicants to go beyond traditional questionnaires alone and adopt modern approaches that better capture exposure timing, intensity, mixtures, and variability.

What are examples of exposure measurement approaches encouraged by the FOA?

Examples mentioned include improved biomonitoring, wearable or sensor-based measurements, geospatial or environmental monitoring linkages, and other modern strategies designed to improve accuracy and comparability of exposure information.

Why is this FOA focused on building new cohorts?

The stated intent is to close major gaps in what is known about cancer causes, particularly where exposure data have historically been weak, inconsistent, or missing. New cohorts are meant to be designed from the start to collect stronger exposure data and follow outcomes over time.

How important are equity and representation in the cohort designs?

Equity and representation are described as core expectations. The cohorts are expected to include racial and ethnic minority groups and other understudied populations, with the explicit goal of addressing unequal cancer burdens and supporting credible analyses of disparities and exposure differences.

What does the FOA imply about recruitment and retention of understudied populations?

The FOA signals that proposals should be intentional about recruitment, retention, community engagement, culturally appropriate study operations, and data completeness so that analyses related to disparities and susceptibility are scientifically credible.

What is the UG3/UH3 phased cooperative agreement structure?

The UG3/UH3 structure is a phased cooperative agreement. Projects typically begin with a time-limited planning and start-up phase (UG3) with specific milestones, and transition to the implementation phase (UH3) only after showing that the cohort can be successfully launched and managed according to those milestones.

What does it mean that this is a cooperative agreement?

As a cooperative agreement, substantial involvement from NCI is expected. This typically includes shared governance, milestone-driven oversight, and coordination across projects to maximize scientific value and promote harmonization where feasible.

How does this opportunity fit into the broader CEECR program?

The cohort awards are intended to operate as part of a broader program. This FOA was published in parallel with a companion solicitation for a CEECR Coordinating Center (RFA-CA-20-050; U24). Together, the funded cohorts and the coordinating center form the Cohorts for Environmental Exposure and Cancer Risk (CEECR) program.

What is the role of the CEECR Coordinating Center in relation to the cohorts?

The coordinating center concept implies expectations that individual cohorts will align on shared practices where feasible. Examples include common data elements, exposure assessment standards, biospecimen procedures, quality control, governance policies, and cross-cohort collaboration to enable pooled or comparative analyses.

Who is offering and sponsoring this funding opportunity?

The opportunity is offered by the U.S. Department of Health and Human Services through the National Institutes of Health (NIH), with the National Cancer Institute (NCI) as the sponsoring institute.

What type of funding mechanism is used?

This is discretionary funding using a cooperative agreement mechanism, specifically UG3/UH3.

What are the listed CFDA numbers for this opportunity?

The listed CFDA numbers are 93.113, 93.393, and 93.399.

What is the anticipated award ceiling and expected number of awards?

The anticipated award ceiling is $750,000, and the opportunity lists an expectation of five awards.

When was this opportunity originally posted and when did it originally close?

The original posting lists a creation date of October 14, 2020 and an original closing date of January 29, 2021.

Who is eligible to apply?

Eligibility is broad and includes many organization types, including: state, county, and local governments; special district governments; independent school districts; public and private institutions of higher education; federally recognized tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses) and small businesses; and other entities as described in the full announcement’s eligibility language.

Why does the FOA allow such a broad range of applicant organizations?

The described rationale is that building and sustaining prospective cohorts requires multidisciplinary capacity, access to diverse populations, and operational infrastructure to recruit, follow participants, and measure exposures and outcomes over time.

What kinds of scientific gaps is this FOA trying to address?

The FOA is aimed at strengthening knowledge about cancer causes by improving the quality and consistency of exposure data and enabling investigation of how environmental exposures contribute to cancer risk and carcinogenesis, especially in areas where exposure information has historically been missing or unreliable.

Does the FOA encourage cross-cohort collaboration?

Yes. The cooperative agreement structure and the coordinating center model point toward coordination across projects, harmonization of key practices where feasible, and collaboration that supports pooled or comparative analyses.

Browse more opportunities from the same agency: Department of Health and Human Services, National Institutes of Health

Browse more opportunities from the same category: Education, Environment, Health

Next opportunity: Leadership Education in Neurodevelopmental and Other Related Disabilities (LEND)

Previous opportunity: Cooperative Ecosystem Studies Unit, Rocky Mountain CESU

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CA 20 049

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 20 049) also looked into and applied for these:

Funding Opportunity
New Cohorts for Environmental Exposures and Cancer Risk (CEECR) Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA CA 20 050

Funding Number: RFA CA 20 050
Agency: Department of Health and Human Services, National Institutes of Health
Category: Education, Environment, Health
Funding Amount: $500,000
TITLE-12192020-SA-S2S-SYN-2 Apply for 12192020 SA S2S SYN 2

Funding Number: 12192020 SA S2S SYN 2
Agency: General Dynamics Information Technology
Category: Education, Environment, Health
Funding Amount: $2,000
Superfund Hazardous Substance Research and Training Program (P42) Apply for RFA ES 15 019

Funding Number: RFA ES 15 019
Agency: National Institutes of Health
Category: Education, Environment, Health
Funding Amount: $1,750,000
Emerging Global Leader Award (K43) Apply for PAR 17 001

Funding Number: PAR 17 001
Agency: National Institutes of Health
Category: Education, Environment, Health
Funding Amount: Case Dependent
Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R01) Apply for PA 17 043

Funding Number: PA 17 043
Agency: National Institutes of Health
Category: Education, Environment, Health
Funding Amount: Case Dependent
Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01) Apply for PA 17 041

Funding Number: PA 17 041
Agency: National Institutes of Health
Category: Education, Environment, Health
Funding Amount: Case Dependent
Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R21) Apply for PA 17 042

Funding Number: PA 17 042
Agency: National Institutes of Health
Category: Education, Environment, Health
Funding Amount: $200,000
Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R21) Apply for PA 17 044

Funding Number: PA 17 044
Agency: National Institutes of Health
Category: Education, Environment, Health
Funding Amount: $200,000
Expanding Genome Integrity Assays to Population Studies (U01) Apply for RFA ES 17 006

Funding Number: RFA ES 17 006
Agency: National Institutes of Health
Category: Education, Environment, Health
Funding Amount: $400,000
Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03) Apply for PA 17 324

Funding Number: PA 17 324
Agency: National Institutes of Health
Category: Education, Environment, Health
Funding Amount: $50,000
Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21) Apply for PA 17 323

Funding Number: PA 17 323
Agency: National Institutes of Health
Category: Education, Environment, Health
Funding Amount: $275,000
Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01) Apply for PA 17 325

Funding Number: PA 17 325
Agency: National Institutes of Health
Category: Education, Environment, Health
Funding Amount: Case Dependent
Administrative Supplements for the U.S.-Japan Brain Research Cooperative Program (BRCP) - U.S. Entity (Admin Supplement) Apply for PA 17 326

Funding Number: PA 17 326
Agency: National Institutes of Health
Category: Education, Environment, Health
Funding Amount: Case Dependent
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed) Apply for PAR 17 476

Funding Number: PAR 17 476
Agency: National Institutes of Health
Category: Education, Environment, Health
Funding Amount: Case Dependent
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed) Apply for PAR 17 475

Funding Number: PAR 17 475
Agency: National Institutes of Health
Category: Education, Environment, Health
Funding Amount: $200,000
Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R01) Apply for PAR 17 484

Funding Number: PAR 17 484
Agency: National Institutes of Health
Category: Education, Environment, Health
Funding Amount: $350,000
Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R21) Apply for PAR 17 483

Funding Number: PAR 17 483
Agency: National Institutes of Health
Category: Education, Environment, Health
Funding Amount: $200,000
Research to Improve Native American Health (R21 Clinical Trial Optional) Apply for PAR 17 464

Funding Number: PAR 17 464
Agency: National Institutes of Health
Category: Education, Environment, Health
Funding Amount: $200,000
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) Apply for PAR 17 496

Funding Number: PAR 17 496
Agency: National Institutes of Health
Category: Education, Environment, Health
Funding Amount: Case Dependent
Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R01 Clinical Trial Optional) Apply for PA 18 284

Funding Number: PA 18 284
Agency: National Institutes of Health
Category: Education, Environment, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 20 049", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: